Ultra Chiron Pharmaceuticals Pvt Ltd
Pharmaceutical company manufacturing and trading products since 1993.
1993 | Chandigarh (India) | Active
Ultra Chiron Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 2.97 M
- Company Age 31 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.10 M
- Revenue Growth -41.24%
- Profit Growth -13.05%
- Ebitda -2.39%
- Net Worth 10.44%
- Total Assets -5.94%
About Ultra Chiron Pharmaceuticals
Ultra Chiron Pharmaceuticals Pvt Ltd (UCPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 20 July 1993 and has a history of 31 years and eight months. Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.97 M.
The company currently has active open charges totaling ₹1.10 M.
Rajesh Shrivastava, Sanjeev Kumar, Gurmit Singh, and Four other members serve as directors at the Company.
Company Details
- Location
Chandigarh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231CH1993PTC013535
- Company No.
013535
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jul 1993
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Pharma
What products or services does Ultra Chiron Pharmaceuticals Pvt Ltd offer?
Ultra Chiron Pharmaceuticals Pvt Ltd offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Common Disease Medicines, Pharmaceutical Syrup, Pharma & Bioanalytical Services, PCD Pharma Franchise, Osteoporosis Medications, Nutraceuticals & Dietary Supplements, Health Supplement, Cardiovascular Drugs & Medication.
Who are the key members and board of directors at Ultra Chiron Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeev Kumar  | Managing Director | 20-Jul-1993 | Current |
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajesh Shrivastava | Director | 16-Aug-2019 | Current |
| Gurmit Singh | Director | 20-Jul-1993 | Current |
| Sadhu Singh | Director | 12-Mar-1999 | Current |
| Mitesh Kumar | Director | 24-Feb-2016 | Current |
| Amrik Singh | Whole-Time Director | 23-Dec-2014 | Current |
| Sudhakar | Director | 11-Sep-2023 | Current |
Financial Performance of Ultra Chiron Pharmaceuticals.
Ultra Chiron Pharmaceuticals Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 41.24% decrease. The company also saw a substantial fall in profitability, with a 13.05% decrease in profit. The company's net worth Soared by an impressive increase of 10.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ultra Chiron Pharmaceuticals?
In 2023, Ultra Chiron Pharmaceuticals had a promoter holding of 99.00% and a public holding of 1.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Preet Remedies LimitedSanjeev Kumar is a mutual person
Quixotic Pharma Private LimitedRajesh Shrivastava, Sanjeev Kumar and 1 more are mutual person
Zenlabs Ethica LimitedSanjeev Kumar is a mutual person
Oasis Pharma And Phytomolecules Private LimitedSanjeev Kumar is a mutual person
- Ultra Chiron Healthcare Private Limited
Sanjeev Kumar and Mitesh Kumar are mutual person
- Quadriga Biotech Private Limited
Sanjeev Kumar is a mutual person
Charges (Loans)
Open Charges
₹1.10 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 0.11 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 May 1997 | Indian Overseas Bank | ₹0.55 M | Open |
| 10 May 1997 | Indian Overseas Bank | ₹0.55 M | Open |
How Many Employees Work at Ultra Chiron Pharmaceuticals?
Unlock and access historical data on people associated with Ultra Chiron Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ultra Chiron Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ultra Chiron Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Ultra Chiron Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Ultra Chiron Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Ultra Chiron Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chandigarh.
- Director Appointment
Mitesh Kumar was appointed as a Director was appointed as a Director on 24 Feb 2016 & has been associated with this company since 9 years 1 month .
- Director Appointment
Amrik Singh was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 23 Dec 2014 & has been associated with this company since 10 years 3 months .
- Director Appointment
Sadhu Singh was appointed as a Director was appointed as a Director on 12 Mar 1999 & has been associated with this company since 26 years 16 days .
- Charges
A charge with Indian Overseas Bank amounted to Rs. 0.55 M with Charge ID 90369917 was registered on 10 May 1997.
Frequently asked questions
What is the Incorporation or founding date of Ultra Chiron Pharmaceuticals Pvt Ltd?
Ultra Chiron Pharmaceuticals Pvt Ltd was incorporated on 20 Jul 1993.
What is authorized share capital and paid-up capital of Ultra Chiron Pharmaceuticals Pvt Ltd?
The authorized share capital of Ultra Chiron Pharmaceuticals Pvt Ltd is ₹ 3.00 M and paid-up capital is ₹ 2.97 M.
Who are the current board members & directors of Ultra Chiron Pharmaceuticals Pvt Ltd?
Currently 7 directors are associated with Ultra Chiron Pharmaceuticals Pvt Ltd.
- Rajesh Biswanath Shrivastava
- Sanjeev Kumar
- Gurmit Singh
- Sadhu Singh
- Mitesh Kumar
- Amrik Singh
- Sudhakar
What is the registered address of Ultra Chiron Pharmaceuticals Pvt Ltd?
As per Ministry of Corporate Affairs (Mca), the registered address of Ultra Chiron Pharmaceuticals Pvt Ltd is Plot No 80 Industrial Area Phase Ii India, Chandigarh, 160001.
What is the corporate identification number (CIN) and company number of Ultra Chiron Pharmaceuticals Pvt Ltd?
The corporate identification number (CIN) of Ultra Chiron Pharmaceuticals Pvt Ltd is U24231CH1993PTC013535 and the company number is 013535 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Ultra Chiron Pharmaceuticals Pvt Ltd?
According to the financial reports for the fiscal year 2023, the revenue trend for Ultra Chiron Pharmaceuticals Pvt Ltd has fallen by -41.24%.
What change has been observed in the net worth of Ultra Chiron Pharmaceuticals Pvt Ltd, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Ultra Chiron Pharmaceuticals Pvt Ltd has experienced an upsurge of 10.44%.
What are the total open charges for Ultra Chiron Pharmaceuticals Pvt Ltd?
As per the financial statements for fiscal Year 2023, The total open charges for Ultra Chiron Pharmaceuticals Pvt Ltd amount to ₹ 1.10 M.
When was the last Balance Sheet of Ultra Chiron Pharmaceuticals Pvt Ltd filed with the ROC?
The most recent Balance Sheet for Ultra Chiron Pharmaceuticals Pvt Ltd was filed with the ROC on 31 Mar 2023.
People also Viewed
Naveesh GuptaDirectorNS
Narang SinghDirectorHC
Hari ChandDirectorDM
Deepak MittalWhole-Time Director